Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
Tóm tắt
Digital health technology, especially digital and health applications (‘apps’), have been developing rapidly to help people manage their diabetes. Numerous health-related apps provided on smartphones and other wireless devices are available to support people with diabetes who need to adopt either lifestyle interventions or medication adjustments in response to glucose-monitoring data. However, regulations and guidelines have not caught up with the burgeoning field to standardise how mobile health apps are reviewed and monitored for patient safety and clinical validity. The available evidence on the safety and effectiveness of mobile health apps, especially for diabetes, remains limited. The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) have therefore conducted a joint review of the current landscape of available diabetes digital health technology (only stand-alone diabetes apps, as opposed to those that are integral to a regulated medical device, such as insulin pumps, continuous glucose monitoring systems, and automated insulin delivery systems) and practices of regulatory authorities and organisations. We found that, across the USA and Europe, mobile apps intended to manage health and wellness are largely unregulated unless they meet the definition of medical devices for therapeutic and/or diagnostic purposes. International organisations, including the International Medical Device Regulators Forum and WHO, have made strides in classifying different types of digital health technology and integrating digital health technology into the field of medical devices. As the diabetes digital health field continues to develop and become more fully integrated into everyday life, we wish to ensure that it is based on the best evidence for safety and efficacy. As a result, we bring to light several issues that the diabetes community, including regulatory authorities, policymakers, professional organisations, researchers, people with diabetes and healthcare professionals, needs to address to ensure that diabetes health technology can meet its full potential. These issues range from inadequate evidence on app accuracy and clinical validity to lack of training provision, poor interoperability and standardisation, and insufficient data security. We conclude with a series of recommended actions to resolve some of these shortcomings.
Tài liệu tham khảo
NCD Risk Factor Collaboration (NCD-RisC) (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387(10027):1513–1530
Gillies CL, Abrams KR, Lambert PC et al (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Br Med J 334(7588):299. https://doi.org/10.1136/bmj.39063.689375.55
Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403. https://doi.org/10.1056/NEJMoa012512
Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343–1350. https://doi.org/10.1056/NEJM200105033441801
Ramchandani N, Heptulla RA (2012) New technologies for diabetes: a review of the present and the future. Int J Pediatr Endocrinol 2012(1):28
Kaufman N, Khurana I (2016) Using digital health technology to prevent and treat diabetes. Diabetes Technol Ther 18(Suppl 1):S56–S68
WHO (2011) mHealth: new horizons for health through mobile technologies. Based on the findings of the second global survey on eHealth. Global Observatory for eHealth series – Volume 3. WHO, Geneva. Available from www.who.int/goe/publications/goe_mhealth_web.pdf. Accessed 17 Sep 2018
Elenko E, Speier A, Zohar D (2015) A regulatory framework emerges for digital medicine. Nat Biotechnol 33(7):697–702. https://doi.org/10.1038/nbt.3284
Statista. Number of mHealth apps available in the Apple App Store from 2nd quarter 2015 to 3rd quarter 2018. Available from www.statista.com/statistics/779910/health-apps-available-ios-worldwide/. Accessed 3 Dec 2018
Pohl M (2017) 325,000 mobile health apps available in 2017 – Android now the leading mHealth platform. Available from https://research2guidance.com/325000-mobile-health-apps-available-in-2017/. Accessed 3 Dec 2018
Martínez-Pérez B, de la Torre-Díez I, López-Coronado M (2013) Mobile health applications for the most prevalent conditions by the World Health Organization: review and analysis. J Med Internet Res 15(6):e120. https://doi.org/10.2196/jmir.2600
American Association of Diabetes Educators (2008) AADE7 self-care behaviours. Diabetes Educ 34:445–449
Kebede MM, Pischke CR (2019) Popular diabetes apps and the impact of diabetes app use on self-care behaviour: a survey among the digital community of persons with diabetes on social media. Front Endocrinol (Lausanne) 10:135. https://doi.org/10.3389/fendo.2019.00135
Bergenstal RM, Johnson M, Powers MA et al (2008) Adjust to target in type 2 diabetes. Diabetes Care 31(7):1305–1310. https://doi.org/10.2337/dc07-2137
Conroy DE, Yang CH, Maher JP (2014) Behavior change techniques in top-ranked mobile apps for physical activity. Am J Prev Med 46(6):649–652. https://doi.org/10.1016/j.amepre.2014.01.010
WellDoc (2017) WellDoc Receives FDA 510(k) Clearance to Offer a Non-Prescription Version of BlueStar® Digital Therapeutic for Type 2 Diabetes. Available from www.welldoc.com/news/welldoc-receives-fda-510k-clearance-to-offer-a-non-prescription-version-of-bluestar-digital-therapeutic-for-type-2-diabetes/. Accessed 6 Sep 2019
Brown A. Can diabetes apps make our lives easier? Lecture presented at: ADA Scientific Sessions; 23 June 2018; Orlando, FL. Available from https://diatribe.org/Apps2018. Accessed 3 Oct 2019
Cision PR Newswire (2019) Hygieia receives 510(k) clearance from FDA for phone app that enhances company’s d-Nav insulin guidance service. Available from www.prnewswire.com/news-releases/hygieia-receives-510k-clearance-from-fda-for-phone-app-that-enhances-companys-d-nav-insulin-guidance-service-300797091.html. Accessed 26 February 2019
Schwartz N. FDA perspective: mobile medical apps in diabetes management. Lecture presented at: Diabetes Technology Meeting; 9 Nov 2018; Bethesda, MD
Companion Medical. InPen. Available from www.companionmedical.com/InPen/. Accessed 7 Dec 2018
Dexcom. Dexcom Clarity. Available from https://clarity.dexcom.com. Accessed 13 Feb 2019
Medtronic. Sugar.IQ™ Diabetes Assistant | Exclusive to Guardian™ Connect CGM. Available from www.medtronicdiabetes.com/products/sugar.iq-diabetes-assistant. Accessed 13 Feb 2019
US Food & Drug Administration. What is the pancreas? What is an artificial pancreas device system? Available from www.fda.gov/medical-devices/artificial-pancreas-device-system/what-pancreas-what-artificial-pancreas-device-system. Accessed 12 Jun 2019
diaTribe. The FDA Approves Medtronic’s MiniMed 670G Hybrid Closed Loop System. Available from https://diatribe.org/fda-approval-medtronic-minimed-670g-hybrid-closed-loop-system. Accessed 3 Oct 2019
Bankmycell.com. How many phones are there in the world? 1 billion more mobile connections than people worldwide. Available from www.bankmycell.com/blog/how-many-phones-are-in-the-world#targetText=AccordingtoStatista,thereis,populationhaveasmartphonetoday. Accessed 6 Sep 2019
Hood M, Wilson R, Corsica J, Bradley L, Chirinos D, Vivo A (2016) What do we know about mobile applications for diabetes self-management? A review of reviews. J Behav Med 39(6):981–994. https://doi.org/10.1007/s10865-016-9765-3
Frøisland DH, Årsand E (2015) Integrating visual dietary documentation in mobile-phone-based self-management application for adolescents with type 1 diabetes. J Diabetes Sci Technol 9(3):541–548. https://doi.org/10.1177/1932296815576956
Turner-McGrievy GM, Beets MW, Moore JB, Kaczynski AT, Barr-Anderson DJ, Tate DF (2013) Comparison of traditional versus mobile app self-monitoring of physical activity and dietary intake among overweight adults participating in an mHealth weight loss program. J Am Med Inform Assoc 20(3):513–518. https://doi.org/10.1136/amiajnl-2012-001510
Huang Z, Tao H, Meng Q, Jing L (2015) Management of endocrine disease. Effects of telecare intervention on glycemic control in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Eur J Endocrinol 172(3):R93–R101. https://doi.org/10.1530/EJE-14-0441
Arnhold M, Quade M, Kirch W (2014) Mobile applications for diabetics: a systematic review and expert-based usability evaluation considering the special requirements of diabetes patients age 50 years or older. J Med Internet Res 16(4):e104
Drincic A, Prahalad P, Greenwood D, Klonoff DC (2016) Evidence-based mobile medical applications in diabetes. Endocrinol Metab Clin N Am 45(4):943–965. https://doi.org/10.1016/j.ecl.2016.06.001
US Food & Drug Administration (2019) Policy for device software fuctions and mobile medical applications. Available from www.fda.gov/media/80958/download. Accessed 8 Nov 2019
Kerr D, Gabbay RA, Klonoff DC (2018) Finding real value from digital diabetes health: is digital health dead or in need of resuscitation? J Diabetes Sci Technol 12(5):911–913. https://doi.org/10.1177/1932296818771200
Schuren J, Califf RM (2016) Need for a national evaluation system for health technology. JAMA 316(11):1153–1154
Sherr JL, Tauschmann M, Battelino T et al (2018) ISPAD clinical practice consensus guidelines 2018: diabetes technologies. Pediatr Diabetes 19(Suppl 27):302–325
European Commission. Guidance document medical devices - scope, field of application, definition - qualification and classification of stand alone software - MEDDEV 2.1/6. Available from http://ec.europa.eu/DocsRoom/documents/17921/attachments/1/translations. Updated July 2016. Accessed 19 Sep 2018
European Commission. Transformation of health and care in the digital single market. Available from https://ec.europa.eu/digital-single-market/en/european-policy-ehealth. Accessed 19 Sep 2018
European Commission. EU health policy. Available from https://ec.europa.eu/health/policies/overview_en. Accessed 19 Sep 2018
Kramer DB, Xu S, Kesselheim AS (2012) Regulation of medical devices in the United States and European Union. N Engl J Med 36(9):848–855
European Commission (2016) The “Blue Guide” on the implementation of EU products rules 2016. Available from https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52016XC0726(02)&rid=7. Accessed 22 Sep 2018
Van Norman GA (2016) Drugs and devices: comparison of European and U.S. approval processes. JACC Basic Transl Sci 1(5):399–412. https://doi.org/10.1016/j.jacbts.2016.06.003
European Commission. Medical Devices Regulatory Framework. Available from https://ec.europa.eu/growth/sectors/medical-devices/regulatory-framework_en. Accessed 13 Feb 2019
Läkemedelsverket Medical Products Agency. Medical information systems – guidance for qualification and classification of standalone software with a medical purpose. Läkemedelsverket Medical Products Agency, Uppsala. Available from https://lakemedelsverket.se/upload/eng-mpa-se/vagledningar_eng/medical-information-system-guideline.pdf. Accessed 20 Sep 2018
European Network of Research Ethics Committee. The Act on Medical Devices (Medical Devices Act) (Medizinproduktegesetz – MPG) (especially §§19–24). Available from www.eurecnet.org/legislation/germany.html. Accessed 20 Sep 2018
US Food & Drug Administration. Mobile medical applications. Available from www.fda.gov/medical-devices/digital-health/mobile-medical-applications. Accessed 6 Sep 2019
US Food & Drug Administration. 21st Century Cures Act. Available from www.fda.gov/regulatoryinformation/lawsenforcedbyfda/significantamendmentstothefdcact/21stcenturycuresact/default.htm. Accessed 19 Sep 2018
US Food & Drug Administration. Digital health. Available from www.fda.gov/MedicalDevices/DigitalHealth/default.htm. Accessed 19 Sep 2018
US Food & Drug Administration. National evaluation system for health technology (NEST). Available from www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cdrh/cdrhreports/ucm301912.htm. Accessed 13 Feb 2019
Shuren J (2018) Changing times at the FDA. Lecture presented at: Diabetes Technology Meeting, 9 Nov 2018, Bethesda, MD
Kvedar JC, Fogel AL, Elenko E, Zohar D (2016) Digital medicine’s march on chronic disease. Nat Biotechnol 34(3):239–246
US Food & Drug Administration (2019) Submitting documents using real-world data and real-world evidence to FDA for drugs and biologics: guidance for industry. Available from www.fda.gov/media/124795/download. Accessed 13 Jun 2019
US Food & Drug Administration. Use of real-world evidence to support regulatory decision-making for medical devices: guidance for industry and food and drug administration staff. Available from www.fda.gov/media/99447/download. Published 31 Aug 2017. Accessed Jun 13, 2019
Brown A, Carracher A, Kurian M, et al. JPM 2019: January 7–10; San Francisco, CA; Day #2 Highlights – Draft. Available from www.closeconcerns.com/knowledgebase/r/5a490a4b. Updated 8 Jan 2019. Accessed 23 Jan 2019
US Food and Drug Administration. Digital health software precertification (Pre-Cert) program. Available from www.fda.gov/MedicalDevices/DigitalHealth/DigitalHealthPreCertProgram/default.htm. Accessed 13 Jun 2019
International medical device regulators forum. Available from www.imdrf.org. Accessed 20 Sept 2018
IMDRF SaMD Working Group (2014) Final document: “Software as a Medical Device”: possible framework for risk categorization and corresponding considerations. Available from www.imdrf.org/docs/imdrf/final/technical/imdrf-tech-140918-samd-framework-risk-categorization-141013.pdf. Accessed 13 Feb 2019
IMDRF SaMD Working Group (2015) Proposed document: software as a medical device (SaMD): application of quality management system. Available from www.imdrf.org/docs/imdrf/final/technical/imdrf-tech-151002-samd-qms.pdf. Accessed 3 Oct 2019
International Medical Device Regulators Forum (2017) Software as a medical device (SAMD): clinical evaluation. Guidance for Industry and Food and Drug Administration Staff. Available from https://www.fda.gov/media/100714/download. Accessed 3 Oct 2019
World Health Organization (2018) Classification of digital health interventions v1.0: A shared language to describe the uses of digital technology for health. Available from https://apps.who.int/iris/bitstream/handle/10665/260480/WHO-RHR-18.06-eng.pdf;jsessionid=CE0199154B170C471D487632C549A142?sequence=1. Accessed 20 Sep 2018
National Health Service. “How we access apps”. Available from https://apps.beta.nhs.uk/how-we-assess-apps/. Accessed 24 Jan 2019
National Health Service. Diabetes-related apps. Available from https://apps.beta.nhs.uk/category/diabetes/. Accessed 24 Jan 2019
Zhao J, Freeman B, Li M (2016) Can mobile phone apps influence people’s health behavior change? An evidence review. J Med Internet Res 18(11):e287. https://doi.org/10.2196/jmir.5692
Veazie S, Winchell K, Gilbert J, et al (2018) Mobile applications for self-management of diabetes. Technical Brief No. 31. (Prepared by the Scientific Resource Center under Contract Nos. 290- 2012-0004-C and 290-2017-00003-C.) AHRQ Publication No. 18-EHC010-EF. Agency for Healthcare Research and Quality, Rockville
Ventola CL (2014) Mobile devices and apps for health care professionals: uses and benefits. P T 39(5):356–364
Baratloo A, Hosseini M, Negida A, el Ashal G (2015) Part 1: simple definition and calculation of accuracy, sensitivity and specificity. Emerg (Tehran) 3(2):48–49
Hogan NM, Kerin MJ (2012) Smart phone apps: smart patients, steer clear. Patient Educ Couns 89(2):360–361. https://doi.org/10.1016/j.pec.2012.07.016
Chavez S, Fedele D, Guo Y, Bernier A, Smith M, Warnick J, Modave F (2017) Mobile apps for the management of diabetes. Diabetes Care 40(10):e145–e146. https://doi.org/10.2337/dc17-0853
Bierbrier R, Lo V, Wu RC (2014) Evaluation of the accuracy of smartphone medical calculation apps. J Med Internet Res 16(2):e32. https://doi.org/10.2196/jmir.3062
Lum E, Jimenez G, Huang Z et al (2019) Decision support and alerts of apps for self-management of blood glucose for type 2 diabetes. JAMA 321(15):1530–1532. https://doi.org/10.1001/jama.2019.1644
Izahar S, Lean QY, Hameed MA et al (2017) Content analysis of mobile health applications on diabetes mellitus. Front Endocrinol (Lausanne) 8:–318
Ristau RA, Yang J, White JR (2013) Evaluation and evolution of diabetes mobile applications: key factors for health care professionals seeking to guide patients. Diabetes Spectrum 26(4):211–215
Apple. Health. Available from www.apple.com/ios/health/. Accessed 3 Oct 2019
Tidepool. Tidepool Mobile. Available from https://tidepool.org/users#mobile. Accessed 13 Feb 2019
Google. Google Fit. Available from www.google.com/fit/. Accessed 13 Feb 2019
Department of Health and Human Services, Centers for Disease Control and Prevention (2017) National Diabetes Statistics Report, 2017: estimates of diabetes and its burden in the United States. CDC, Atlanta
Ahn D. Advances in BGM logbooks and apps. Lecture presented at: Diabetes Technology Meeting, 8 Nov 2018, Bethesda, MD
Rose KJ, König M, Wiesbauer F. Evaluating success for behavorial change in diabetes via mHealth and gamification: mySugr’s keys to retention and patient engagement. Poster presented at: Advanced Technologies and Treatments for Diabetes; 27 Feb – 3 Mar, 2013; Paris, France. Available from https://assets.mysugr.com/website/mysugr.com-wordpress/uploads/2017/03/attd-2013-poster.pdf. Accessed 3 Oct 2019
Medtronic (2018) Medtronic launches patient engagement program that leverages gamification to help motivate and engage patients living with diabetes. Available from http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=2363121. Accessed 24 Jan 2018
Levine B, Brown A, and Close K (2018) Close Concerns. UnitedHealthcare adds Apple Watch to Motion physical activity incentives program; people with diabetes 40% more likely to enroll in Motion. Available from www.closeconcerns.com/knowledgebase/r/96d89360. Accessed 24 Jan 2019
Sardi L, Idri A, Fernandez-Aleman JL (2017) A systematic review of gamification in e-Health. J Biomed Inform 71:3148
Blenner SR, Köllmer M, Rouse AJ, Daneshvar N, Williams C, Andrews LB (2016) Privacy policies of android diabetes apps and sharing of health information. JAMA 315(10):1051–1052. https://doi.org/10.1001/jama.2015.19426
Klonoff DC (2015) Cybersecurity for connected diabetes devices. J Diabetes Sci Technol 9(5):1143–1147. https://doi.org/10.1177/1932296815583334
Diabetes Technology Society (2017) Standard for wireless diabetes device security (DTSec). Available from www.diabetestechnology.org/dtsec/DTSecStandard.pdf. Accessed 16 Nov 2018
Wyatt JC (2018) How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use? BMC Med 16:225